You have 9 free searches left this month | for more free features.

stage IV esophageal cancer

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Apr 4, 2019

Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

Recruiting
  • Cancer
  • +3 more
  • Aalborg, Denmark
  • +6 more
Oct 25, 2022

HER2-positive Breast Cancer Trial in Shanghai (68Ga/131I-SGMIB-5F7)

Not yet recruiting
  • HER2-positive Breast Cancer
  • 68Ga/131I-SGMIB-5F7
  • Shanghai, China
    Huashan Hospital
Aug 1, 2023

Data Acquisition for Connected Network for EMSs Comprehensive

Completed
  • Emergency Patients Being Transported by Rescue Ambulance
    • Seoul, Korea, Republic of
      Severance hospital
    Jul 3, 2023

    Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing

    Recruiting
    • Carcinoma
    • +4 more
      • Nanjing, Jiangsu, China
        Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
      Jun 30, 2023

      Prostate Cancer Trial in Herlev (Focal Brachytherapy)

      Enrolling by invitation
      • Prostate Cancer
      • Focal Brachytherapy
      • Herlev, Denmark
        Department of Urology, Herlev University Hospital Herlev
      Oct 12, 2023

      Breast Cancer Female Trial in Coimbra (Mind, Support Group)

      Recruiting
      • Breast Cancer Female
      • Mind
      • Support Group
      • Coimbra, Portugal
        Radiotherapy Service of the Coimbra University Hospital (CHUC)
      Jan 16, 2023

      Prostate Cancer, Magnetic Resonance Imaging, Population at Risk Trial in Lake Success (Bi-parametric MRI)

      Recruiting
      • Prostate Cancer
      • +2 more
      • Bi-parametric MRI
      • Lake Success, New York
        Cynthia Knauer
      Aug 26, 2022

      Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)

      Active, not recruiting
      • Breast Cancer
      • San Francisco, California
      • +17 more
      Jan 30, 2023

      Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)

      Not yet recruiting
      • Advanced or Metastatic Breast Cancer
      • (no location specified)
      Oct 24, 2023

      Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)

      Unknown status
      • Lymphoma
      • immunoscintigraphy
      • technetium Tc 99m epratuzumab
      • Los Angeles, California
      • +7 more
      Aug 12, 2021

      Interstitial Lung Disease Within a Lung Cancer Screening

      Completed
      • Interstitial Lung Disease
        • Manchester, Greater Manchester, United Kingdom
          Manchester University NHS foundation trust
        Jan 14, 2021

        Tailoring Shared Decision Making for Lung Cancer Screening in

        Enrolling by invitation
        • Lung Carcinoma
        • Behavioral Intervention
        • +4 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Dec 23, 2022

        Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma Trial in Philadelphia (drug, procedure, other)

        Recruiting
        • Recurrent Renal Cell Carcinoma
        • Renal Cell Carcinoma
        • Sulfur Hexafluoride Lipid Microspheres
        • +4 more
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Nov 29, 2022

        Cancer, Lung, Cancer, Head and Neck Trial in Denver, Grand Junction (Stepped-Care Intervention, Enhanced Usual Care)

        Completed
        • Cancer, Lung
        • Cancer, Head and Neck
        • Stepped-Care Intervention
        • Enhanced Usual Care
        • Denver, Colorado
        • +4 more
        Feb 24, 2021

        Moderate Alzheimer's Disease Trial (GV1001, Normal saline)

        Withdrawn
        • Moderate Alzheimer's Disease
        • (no location specified)
        Feb 15, 2022

        Hepatocellular Carcinoma Trial in New Taipei City, Hualien City, Taipei (ATL administration)

        Recruiting
        • Hepatocellular Carcinoma
        • ATL administration
        • New Taipei City, Taiwan (R. O. C.), Taiwan
        • +3 more
        Jun 10, 2022

        Hyperkalemia, End Stage Renal Disease Trial in Durham (Patiromer Oral Powder Product)

        Enrolling by invitation
        • Hyperkalemia
        • End Stage Renal Disease
        • Patiromer Oral Powder Product
        • Durham, North Carolina
          DaVita Dialysis Sites
        Jun 10, 2022

        Bipolar Disorder, Non-Adherence, Medication, Hypertension Trial in Cleveland (iTAB-CV, Self-Monitoring)

        Recruiting
        • Bipolar Disorder
        • +2 more
        • iTAB-CV
        • Self-Monitoring
        • Cleveland, Ohio
          Case Western Reserve University
        Jul 22, 2022

        Distress, Emotional, Sleep Trial in Taipei (Kombucha)

        Recruiting
        • Distress, Emotional
        • Sleep
        • Kombucha
        • Taipei, Taiwan
          National Yang-Ming University
        Feb 6, 2023

        Brentuximab Vedotin for IV Infusion - Special Drug Use

        Completed
        • Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma
        • Brentuximab vedotin (recombinant)
        • Osaka, Japan
          (unnamed)
        Jun 25, 2020

        Barrett Esophagus Trial in Groningen (Bevacizumab-IRDye800CW, Fluorescence endoscopy)

        Recruiting
        • Barrett Esophagus
        • Groningen, Netherlands
          University Medical Center Groningen
        Nov 3, 2020

        Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Canada, United States (other, device, behavioral)

        Recruiting
        • Hematopoietic and Lymphoid Cell Neoplasm
        • Malignant Solid Neoplasm
        • Educational Intervention
        • +5 more
        • Mobile, Alabama
        • +110 more
        Jan 30, 2023

        Lung Non-Small Cell Carcinoma Trial in Buffalo (Pembrolizumab)

        Active, not recruiting
        • Lung Non-Small Cell Carcinoma
        • Pembrolizumab
        • Buffalo, New York
          Roswell Park Cancer Institute
        Jan 27, 2023

        Evaluating Disparities in Precision Oncology

        Not yet recruiting
        • Metastatic Cancer
        • Advanced Cancer
        • Social Determinants of Health and toxicity questionnaires
        • Indianapolis, Indiana
          Indiana University Health Melvin and Bren Simon Comprehensive Ca
        Oct 7, 2023